The Asian Pacific Association for the Study of the Liver [APASL]

Now following APASL Guidelines have been published in Hepatology International !!!


Asian Pacific Association for the Study of the Liver Consensus Recommendations on Hepatocellular Carcinoma-2010

APASL Consensus Statements and Management Algorithms for Hepatitis C Virus Infection-2012

Asian-Pacific Consensus statement on the management of chronic hepatitis B: A 2012 update-2012

Acute-on-chronic liver failure: An Update on Consensus Recommendations of the Asian Pacific Association for the Study of the Liver (APASL)-2014

ASIAN-PACIFIC CLINICAL PRACTICE GUIDELINES ON THE MANAGEMENT OF HEPATITIS B: A 2015 UPDATE-2015

APASL consensus statements and recommendation on treatment of hepatitis C-2016

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology and laboratory testing-2016

ASIAN-PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL) CONSENSUS GUIDELINES ON INVASIVE AND NON-INVASIVE ASSESSMENT OF HEPATIC FIBROSIS: A 2016 UPDA-2016

Asia-Pacific clinical practice guideline on the management of hepatocellular carcinoma: a 2016 update-2017

APASL clinical practice recommendation: How to treat HCV-infected patients with renal impairment?-2018

APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation-2019

ACUTE-ON-CHRONIC LIVER FAILURE: CONSENSUS RECOMMENDATIONS OF THE ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL), AN UPDATE-2019

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseases-2020

Asia-Pacific Association for the Study of the Liver Clinical Practice Guidance: The diagnosis and management of patients with autoimmune hepatitis-2021

Budd-Chiari Syndrome: Consensus Guidelines of the Asian Pacific Association for the Study of the Liver (APASL)-2021

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy-2021

APASL Clinical Practice Guidance: The diagnosis and management of patients with primary biliary cholangitis-2021

APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients-2021

Asian Pacific Association for the Study of Liver (APASL) Guidelines: Hepatitis B Virus in Pregnancy-2021

Drug-Induced Liver Injury: Asia Pacific Association of Study of Liver Consensus Guidelines-2021

Asian Pacific Association for the Study of the Liver Clinical Practice Guidelines on Liver Transplantation-2023

Clinical Practice Guidelines on Haemochromatosis: Asian Pacific Association for the Study of the Liver-2023

Asia Pacific Association for Study of Liver Guidelines on Management of Ascites in Liver Disease-2023

APASL clinical practice guideline on systemic therapy for hepatocellular carcinoma-2024-2024

Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management-2024

The Asian Pacific Association for the Study of the Liver clinical practice guideline for the diagnosis and management of metabolic dysfunction-associated fatty liver disease-2024

APASL CLINICAL PRACTICE GUIDELINES ON THE MANAGEMENT OF ACUTE KIDNEY INJURY IN ACUTE-ON-CHRONIC LIVER FAILURE-2024

Acute-on-chronic liver failure (ACLF) – The ‘Kyoto Consensus’: Steps from Asia-2024